PCP News Agency Pune/B’luru (Spl Corr) 18 April 2020 ; First low-Cost COVID-19 Diagnostic Test kit that can confirm Corona in just two hours has been developed in India, by the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),which is also the first through-out World and funded by the Department of Science and Technology, called Chitra GeneLAMP-N, is highly specific for SARS-CoV-2 N-gene and can detect two regions of the gene which will ensure that the test does not fail even if one region of the viral gene undergoes mutation during its current spread. The detection time is 10 minutes and the sample-to-result time — from RNA extraction in swab to RT LAMP detection time — will be less than two hours. A total of 30 samples can be tested in a single batch in a single machine allowing a large number of samples to be tested each day.
While speaking with PCP News Correspondent, Prof Ashutosh Sharma, secretary GST, said that the development of a novel, inexpensive, rapid confirmatory for the diagnosis is a compelling example of how a creative team of clinicians and scientists working together seamlessly can leverage knowledge and infrastructure to make relevant breakthroughs. “This will have a global impact,”.
According to SCTIMST, the testing facility can be easily set up even in the laboratories of district hospitals with limited facilities and trained laboratory technicians. The results can be read from the machine from the change in fluorescence. “The cost of testing with the new device for LAMP testing and the test kit for two regions of N-gene( including RNA extraction) will be less than Rs 1,000/test for the laboratory,”.
Sree Chitra has also additionally developed the specific RNA extraction kits along with GeneLAMP-N test kit and testing device. The technology was transferred for manufacture to Agappe Diagnostics Ltd, Ernakulam, a leading company in In-vitro diagnostics with national and international operations. Dr Anoop Thekkuveettil, senior scientist of the Biomedical Technology wing of the Institute and Scientist-in-charge of the division of molecular medicine under the department of applied biology and his team developed the kit in the last three weeks.
An Institute of National Importance under DST, SCTIMST’s new device, the DST believes, will be one of the world’s first few if not the first of its kind in the world. PCP/IDN/DJ/ 09 45